Previous studies have demonstrated that CSMD1 can restrict cancer progression by inhibiting esophageal squamous cell carcinoma proliferation, epithelial-mesenchymal transition, chemotherapy resistance, and inducing immunosuppression [28]. The gene discussed is CSMD1; the disease is esophageal squamous cell carcinoma.